# US 6,730,129 B1 · Implant for application in bone, method for producing such an implant, and use of such an implant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,129 B1
- Document ID: US6730129B1
- Status: Granted
- Kind: B1
- Application number: 09/980,065
- Filed: 2002-02-28
- Granted: 2004-05-04
- Earliest claimed: 1999-05-31
- Assignees: Nobel Biocare AB
- Inventors: Jan Hall
- Web page: https://patentgrep.com/patent/US6730129B1

## CPC

- A61L 27/32: Phosphorus-containing materials, e.g. apatite
- A61C 8/0006: {Periodontal tissue or bone regeneration (support means for endoprosthetic bone substitute or bone graft implants A61F2/2846)}
- A61C 8/0012: {characterised by the material or composition, e.g. ceramics, surface layer, metal alloy (use of specific materials A61K6/00)}
- A61C 8/0013: {with a surface layer, coating}
- A61C 8/0022: {Self-screwing (A61C8/0028 takes precedence)}
- A61L 27/06: Titanium or titanium alloys
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2300/414: Growth factors
- A61L 2300/602: Type of release, e.g. controlled, sustained, slow
- A61L 2300/608: having two or more layers
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)

## Abstract

An implant for application in bone, especially jaw bone, is provided. The implant includes a unit that can be applied in the bone, and which is made of a biocompatible material such as titanium. The unit is provided with one or more coatings including calcium phosphate and a bone-growth-stimulating substance that initiates and/or stimulates bone growth. The coating is applied at least to surface parts of the unit cooperating with the bone. A method of producing the implant is also provided.

## Claims

### Claim 1

An implant for application in bone, said implant comprising a unit adapted to be applied in the bone, said unit being made of biocompatible material, wherein the implant includes at least one coating of at least one calcium phosphate layer comprising at least one calcium phosphate compound, and at least one bone-growth-stimulating layer comprising a bone-growth-stimulating substance applied on the at least one calcium phosphate layer, wherein the at least one coating is provided at least on surface parts of the implant cooperating with the bone, and wherein the at least one calcium phosphate layer and the at least one bone-growth stimulating layer are arranged to effect an initial optimal bone structure around the implant in combination with long term bone growth or bone-growth or bone-growth-promoting function.

### Claim 2 (depends on 1)

An implant according to claim 1, wherein the at least one calcium phosphate layer has a thickness in the range of between a few angstroms and 10 μm, and wherein the at least one bone-growth-stimulating layer has a thickness of between a few angstroms and 1 μm.

### Claim 3 (depends on 1)

An implant according to claim 1, wherein all areas of said surface parts are provided with the at least one coating.

### Claim 4 (depends on 1)

An implant according to claim 1, wherein the at least one calcium phosphate layer is located nearest to or on the actual surfaces of the implant, and wherein the at least one bone-growth-stimulating layer is located on the at least one calcium phosphate layer or on an outermost one of the at least one calcium phosphate layer.

### Claim 5 (depends on 1)

An implant according to claim 1, wherein the at least one calcium phosphate layer has a high degree of crystallization such that the at least one calcium phosphate layer functions as a support for the at least one bone-growth-stimulating layer.

### Claim 6 (depends on 1)

An implant according to claim 1, wherein the at least one bone-growth-stimulating layer comprises a plurality of bone-growth-stimulating layers, and wherein at least one layer or agent with a release-retarding function for the bone-growth-stimulating substance is interleaved with the bone-growth-stimulating layers.

### Claim 7 (depends on 1)

An implant according to claim 1, wherein one or more layers among the at least one calcium phosphate layer contain hydroxyapatite or HA, and wherein one or more layers among the at least one bone-growth-stimulating layer consist of a substance belonging to the superfamily TGF-β.

### Claim 8 (depends on 1)

An implant according to claim 1, wherein the at least one calcium phosphate layer has a thickness in the range of between 0.1 μm and 20 μm, and wherein the at least one bone-growth-stimulating layer has a thickness of between a few angstroms and 1 μm.

### Claim 9 (depends on 1)

An implant according to claim 1, wherein the at least one calcium phosphate layer has a low or medium-high degree of crystallization such that the at least one calcium phosphate layer functions as a support for the at least one bone-growth-stimulating layer.

### Claim 10 (depends on 9)

An implant according to claim 9, wherein at least one layer of a release-retarding agent is included in a bone-growth-stimulating function.

### Claim 11 (depends on 1)

An implant according to claim 1, wherein one or more layers among the at least one bone-growth-stimulating layer with release-retarding agents can be released with components occurring naturally in the bone and/or tissue.

### Claim 12 (depends on 11)

An implant according to claim 11, wherein the at least one calcium phosphate layer, the at least one bone-growth stimulating layer and the release-retarding agents are arranged or chosen to generate bone formation in the surrounding tissue around the implant without the risk of excessively rapid bone build-up and bone fracture tendencies.

### Claim 13 (depends on 1)

An implant according to claim 1, wherein a release time for agents in said at least one coating is chosen by setting a release time for the at least one calcium phosphate compound and a release time for the bone-growth-stimulating substance in relation to each other.

### Claim 14 (depends on 13)

An implant according to claim 13, wherein a release time for the at least one calcium phosphate compound is chosen with the aid of a degree of crystallization in the at least one calcium phosphate compound, wherein a higher degree of crystallization gives a longer release time, and wherein a lower degree of crystallization gives a shorter release time.

### Claim 15 (depends on 14)

An implant according to claim 14, wherein the degree of crystallization in the at least one calcium phosphate compound is chosen to give a total release time of at least 2-4 weeks up to several months.

### Claim 16 (depends on 1)

An implant according to claim 1, wherein the at least one coating further comprises at least one layer of release-retarding agents.

### Claim 17 (depends on 16)

An implant according to claim 16, wherein the release-retarding agent is hyaluronic acid.

### Claim 18 (depends on 16)

An implant according to claim 16, wherein the at least one calcium phosphate layer has a high degree of crystallization such that the at least one calcium phosphate layer functions as a support for the at least one bone-growth-stimulating layer and the release-retarding agent.

### Claim 19

A method for arranging at least one coating on an implant for application in bone, wherein said implant comprises a unit of biocompatible material, wherein the coating is applied at least on surface parts of the unit cooperating with the bone, the method comprising: coating the surface parts or the whole unit with at least one calcium phosphate compound; applying at least one bone-growth-stimulating substance on the at least one calcium phosphate compound, wherein the at least one calcium phosphate compound is X-ray-amorphous or given a specific degree of crystallization; and applying a release-retarding-agent by painting on the at least one bone-growth stimulating substance.

### Claim 20 (depends on 19)

A method according to claim 19, wherein the release-retarding agent is hyaluronic acid or a visco-elastic substance.

### Claim 21 (depends on 19)

A method according to claim 19, wherein the calcium phosphate compound is first applied and crystallized completely or partially in at least one calcium phosphate layer and wherein the bone-growth stimulating substance is then applied in at least one bone-growth stimulating layer by immersing the unit or parts of the unit in a bath of bone-growth-stimulating substance or by dropping bone-growth-stimulating solution on the unit or parts of the unit.

### Claim 22 (depends on 21)

A method according to claim 21, wherein the at least one bone-growth-stimulating layer comprises several bone-growth-stimulating layers, wherein a first bone-growth-stimulating layer is obtained by immersing in or dropping on a bone-growth-stimulating solution at a chosen concentration, wherein a second bone-growth-stimulating layer is obtained, after drying of the first bone-growth-stimulating layer, by dropping on or painting on a bone-growth-stimulating solution at said chosen concentration or a second concentration which differs from said chosen concentration, and wherein a third bone-growth-stimulating layer is obtained, after drying of the second bone-growth-stimulating layer, by dropping on or painting on a bone-growth-stimulating solution at said chosen concentration or a third concentration which differs from said chosen and/or said second concentration.

### Claim 23 (depends on 19)

A method according to claim 19, wherein the at least one calcium phosphate compound is applied by sputtering of a calcium phosphate substance in at least one calcium phosphate layer on originally essentially amorphous implant surfaces and by subsequent heat treatment.

### Claim 24 (depends on 23)

A method according to claim 23, further comprising applying and heat treating the at least one calcium phosphate compound such that depressions are obtained in the at least one calcium phosphate layer, wherein the depressions contribute to increasing the attachment of an outer bone-growth-stimulating layer in the at least one calcium phosphate layer, and wherein the biocompatible material comprises titanium.

### Claim 25

A method for arranging at least one coating on an implant for application in bone, wherein said implant comprises a unit of biocompatible material comprising titanium, wherein the coating is applied at least on surface parts of the unit cooperating with the bone, the method comprising: coating the surface parts or the whole unit with at least one calcium phosphate compound by sputtering of a calcium phosphate substance in at least one calcium phosphate layer on originally essentially amorphous implant surfaces and by subsequently heat treating the at least one calcium phosphate compound such that depressions are obtained in the at least on calcium phosphate layer; and applying at least one bone-growth-stimulating substance on the at least one calcium phosphate compound, wherein the at least one calcium phosphate compound is X-ray-amorphous or given a specific degree of crystallization, and wherein the depressions contribute to increasing the attachment of an outer bone-growth-stimulating layer in the at least one calcium phosphate layer.
